These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 325823)
1. Anticipation of renal transplant failure by postanastomosis biopsy and immunofluorescence. Tourville DR; Kim DU; Viscuso R; Jacobs M; Schoen S; Fillipone D Transplant Proc; 1977 Mar; 9(1):91-5. PubMed ID: 325823 [TBL] [Abstract][Full Text] [Related]
2. Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome. Worthington JE; McEwen A; McWilliam LJ; Picton ML; Martin S Transplantation; 2007 Feb; 83(4):398-403. PubMed ID: 17318071 [TBL] [Abstract][Full Text] [Related]
3. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant? Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907 [TBL] [Abstract][Full Text] [Related]
4. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M Clin Transpl; 2007; ():219-26. PubMed ID: 18642453 [TBL] [Abstract][Full Text] [Related]
5. C4d deposition in allograft renal biopsies is an independent risk factor for graft failure. Wang R; Wang H; Chen J; Wu J; Wang Y; Huang H; He Q Nephrology (Carlton); 2009 Aug; 14(5):527-32. PubMed ID: 19674321 [TBL] [Abstract][Full Text] [Related]
6. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of C4d in renal allograft biopsies in different clinical settings: absence of C4d in grafts from non-heart-beating donors. Crespo M; Sole M; Arostegui JL; Mila J; Martorell J; Oppenheimer F Transplant Proc; 2005 Nov; 37(9):3688-9. PubMed ID: 16386506 [TBL] [Abstract][Full Text] [Related]
14. Oxalate deposits in biopsies from native and transplanted kidneys, and impact on graft function. Bagnasco SM; Mohammed BS; Mani H; Gandolfo MT; Haas M; Racusen LC; Montgomery RA; Kraus E Nephrol Dial Transplant; 2009 Apr; 24(4):1319-25. PubMed ID: 19103737 [TBL] [Abstract][Full Text] [Related]
15. A clinicopathologic study of isolated intestinal allografts with preformed IgG lymphocytotoxic antibodies. Wu T; Abu-Elmagd K; Bond G; Demetris AJ Hum Pathol; 2004 Nov; 35(11):1332-9. PubMed ID: 15668889 [TBL] [Abstract][Full Text] [Related]
18. IgM antibodies in renal transplantation. McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684 [TBL] [Abstract][Full Text] [Related]
19. Protocol biopsies in kidney transplant recipients: histologic findings as prognostic markers for graft function and outcome. Masin-Spasovska J; Spasovski G; Dzikova S; Grcevska L; Petrusevska G; Lekovski Lj; Popov Z; Ivanovski N Transplant Proc; 2005 Mar; 37(2):705-8. PubMed ID: 15848508 [TBL] [Abstract][Full Text] [Related]
20. Comparative study for the detection of peritubular capillary C4d deposition in human renal allografts using different methodologies. Nadasdy GM; Bott C; Cowden D; Pelletier R; Ferguson R; Nadasdy T Hum Pathol; 2005 Nov; 36(11):1178-85. PubMed ID: 16260271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]